Rocket Pharmaceuticals Inc (RCKT)
EBITDA Growth
304.06%
Quarterly · Period ending:
RCKT EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported304.06%period ending
Latest reported304.06%period ending
RCKT Quarterly EBITDA YoY % (-2.33% → 304.06%)
Year-over-year change
High-resolution chart · PNG
RCKT ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 304.0643% | |
| 22.2867% | |
| 35.6235% | |
| 26.997% | |
| 1.4026% | |
| 2.4541% | |
| -0.4157% | |
| -7.0185% | |
| -5.1998% | |
| -5.5789% | |
| 12.6665% | |
| -7.4863% | |
| -22.178% | |
| -38.276% | |
| -64.7294% | |
| -15.5792% | |
| -58.2625% | |
| -9.4299% | |
| 31.8189% | |
| -80.5986% | |
| -42.7497% | |
| -61.655% | |
| -212.8806% | |
| -50.1072% | |
| -32.6071% | |
| -29.0473% | |
| 27.2642% | |
| -19.4177% | |
| -21.0677% | |
| -26.9848% | |
| -554.4782% | |
| -121.0189% | |
| -337.4237% | |
| -429.0189% | |
| 67.4041% | |
| 36.454% | |
| 62.6879% | |
| 73.8581% | |
| -46.0165% | |
| -94.2983% | |
| -381.888% | |
| -232.4697% | |
| -380.9579% | |
| -160.6424% | |
| 16.9553% | |
| -78.0958% | |
| -2.3311% |